About the Journal of Respiratory Diseases
Advancing mechanistic understanding of respiratory pathophysiology through rigorous peer-reviewed research on molecular pathways, disease biomarkers, and cellular mechanisms underlying pulmonary disorders.
JRD occupies a distinct position in respiratory science by emphasizing pathophysiological mechanisms rather than clinical practice. Our scope encompasses research that answers fundamental questions: How do respiratory diseases initiate and progress? What molecular pathways drive pathogenesis? Which biomarkers can accurately reflect disease activity? What cellular mechanisms can be targeted for intervention?
This mechanistic focus creates value for researchers working at the intersection of basic science and translational medicine. We welcome studies employing molecular biology, biochemistry, cell biology, systems biology, omics technologies, and animal disease models that generate mechanistic insight applicable across respiratory pathology.
JRD actively seeks manuscripts investigating the molecular and cellular mechanisms underlying respiratory diseases across multiple thematic areas:
Pathway analysis, gene regulation, protein interactions, and signaling cascades in asthma, COPD, bronchiolitis, and bronchiectasis.
Immune cell activation, cytokine networks, inflammasome signaling, and inflammatory pathway dysregulation in respiratory pathology.
Fibroblast activation, extracellular matrix remodeling, epithelial-mesenchymal transition, and molecular drivers of pulmonary fibrosis.
Host-pathogen interactions, microbial virulence factors, immune evasion strategies, and molecular pathogenesis of tuberculosis, pneumonia, and viral respiratory infections.
Endothelial dysfunction, coagulation cascade activation, vascular remodeling, and molecular mechanisms of pulmonary embolism and pulmonary hypertension.
Identification and mechanistic validation of molecular, cellular, and biochemical biomarkers for disease diagnosis, progression monitoring, and therapeutic response prediction.
In vitro cell culture systems, organoid models, and animal models that recapitulate human respiratory disease pathophysiology for mechanistic investigation.
Mechanism of action studies, drug-target interactions, pharmacogenomics, and molecular pathways modulated by respiratory therapeutics.
Genomics, transcriptomics, proteomics, metabolomics, and systems biology investigations revealing molecular signatures and pathway networks in respiratory disease.
JRD maintains scientific rigor through a comprehensive peer review process that evaluates mechanistic insight, methodological soundness, and reproducibility. Each submission receives editorial screening for scope alignment before assignment to expert reviewers with specialized knowledge in respiratory pathophysiology.
Review Standards
- Mechanistic clarity and novelty assessment
- Methodological rigor and reproducibility evaluation
- Statistical analysis verification
- Data quality and presentation review
- Ethical compliance confirmation
- Biomarker validation criteria assessment
Editorial Safeguards
- Similarity screening via iThenticate
- Conflict of interest disclosure requirements
- Research ethics documentation
- Data availability statement verification
- Transparent decision communication
- Post-publication correction mechanisms
JRD's streamlined workflow enables rapid dissemination while maintaining editorial quality. Authors can submit manuscripts through the online submission portal or via email to [email protected]. Our editorial team provides responsive communication throughout the review and production process.
Manuscripts undergo editorial assessment for scope alignment, format compliance, and ethical documentation. Authors receive acknowledgment within 72 hours and scope feedback within 5 days.
In-scope manuscripts are assigned to 2-3 expert reviewers specializing in relevant pathophysiological domains. Single-blind or double-blind review options available.
Authors receive first decisions within 12 days on average. Revisions are accompanied by detailed reviewer feedback and clear revision expectations.
Accepted manuscripts proceed to copyediting, author proof approval, and online publication within 48 hours of final acceptance.
JRD operates under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, ensuring unrestricted access to published research. This open access model eliminates barriers to knowledge dissemination, enabling researchers, educators, and scientists worldwide to access mechanistic insights that advance the field.
Articles are indexed across major academic databases and discovery platforms including Google Scholar, ResearchGate, Academia.edu, and discipline-specific repositories. DOI assignment through Crossref ensures permanent citation tracking and scholarly integration.
JRD supports equitable access to publication through transparent article processing charges (APC) with waiver consideration for authors from low-income countries and early-career researchers facing financial constraints.
JRD has established research partnerships with leading institutions contributing to respiratory disease pathophysiology. Our collaborative network includes:
Publishing with Open Access Pub journals provided an exceptional experience from start to finish. The registration and submission process was straightforward, with clear guidance at every step. The qualified reviewing process was conducted efficiently, and the timeline from submission to publication was remarkably fast compared to other journals I've worked with.
The editorial team demonstrated a positive, cooperative attitude that was both encouraging and supportive throughout the publication process. The rapid response times and efficient manuscript processing reflected a strong appreciation for authors' time. The user-friendly submission system allowed for real-time tracking, and the peer review was completed in reasonable time with constructive feedback aimed at improving manuscript quality. This level of communication between authors and journals is increasingly rare in academic publishing.
Advance Respiratory Disease Mechanisms Research
Join the growing community of researchers unraveling the molecular foundations of respiratory pathology. Publish your mechanistic discoveries, biomarker studies, and disease pathway research with JRD.
